Takeda Pharmaceutical Co., Ltd. (4502)
Market Closed
15 Jun, 06:00
¥
5,088. 00
+6
+0.1181%
¥
7.12T Market Cap
37.11 P/E Ratio
2.85% Div Yield
3.45M Volume
0 Eps
¥ 5,082
Previous Close Want to track 4502 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Takeda Pharmaceutical Co., Ltd. (4502) Statistics
Valuation metrics
Market Cap 7.12T
Enterprise value 12.32T
Trailing P/E (ttm) 41.41
Forward P/E 37.59
PEG ratio 0.53
Price/Sales (ttm) 1.78
Price/Book (mrq) 1.02
Enterprise Value/Revenue 2.73
Enterprise Value/EBITDA 9.06
Overview
Shares outstanding 1.58B
Float 1.58B
Shares short -
% Held by insiders 0%
% Held by institutions 0.5%
Average volume (10 days) 3.64M
Average volume (90 days) 4.2M
Price summary
52-Week low 4,102
52-Week high 6,033
Beta 0.1
50-Day moving average 5,125.19
200-Day moving average 5,242.26
Dividends and splits
Forward annual dividend rate 200
Forward annual dividend yield 0.0379%
Trailing annual dividend rate 200
Trailing annual dividend yield 0.0394%
5-Year annual dividend yield 4.53%
Payout ratio 1.63
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.04%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.03%
Income Statement
Revenue (ttm) 4.51T
Revenue per share (ttm) 2,883.52
Quarterly revenue growth (yoy) 0.04%
Gross profit (ttm) 2.93T
EBITDA 1.28T
Net income to common (ttm) 191.76B
Diluted EPS (ttm) 122.72
Quarterly earnings growth (yoy) 0.04%
Balance Sheet
Total cash (mrq) 595.05B
Total cash per share (mrq) 380.82
Total debt (mrq) 5.45T
Total Debt/Equity (mrq) 0.63
Current ratio (mrq) 1.27%
Book value per share (mrq) 4,975.63
Cash Flow
Cash flow statement 1.04T
Levered free cash flow (LFCF) 356.63B
